News

News Archive

 


12/12/14 - Holiday Greetings From The RIFM Staff

 

 

2/12/13 - RIFM Welcomes Lambros Kromidas, Ph.D.

Lambros Kromidas, Ph.D. joins RIFM as Vice President, Risk Assessment. He will be responsible for setting the objectives and managing timelines to ensure that RIFM's fragrance material safety evaluations are completed on time and include appropriate scientific advances in research and methodology.

5/3/12 - RIFM Launches 2-Box Indoor Air Dispersion Model Beta Test

Find out more about RIFM's 2-Box Indoor Air Dispersion Model, beta testing now. The 2-Box Model a computational, indoor environment, air exposure model that characterizes the movement of a single chemical inside two connected, enclosed rooms. The model allows the user to determine air concentrations, over time, to assess potential inhalation exposure for different air care products under defined conditions of consumer use. RIFM will collect feedback during this period that will contribute to future enhancements of the model.

3/8/12 - Reproduction Adjunct Group Welcomes Dr. Kohei Shiota

11/14/11 - RIFM President Dr. Ladd W. Smith Announces Retirement

Dr. Ladd W. Smith announces his retirement after 13 years as RIFM's President.

9/20/10 - Finally the Fragrance Industry is Understood

"When it comes to the alleged toxicity of perfumes and fragrances, there's nothing worse than non-scientists eschewing readily-available scientific research in favor of village idiocy found on the internet, . . ." Lawrence Meyers

5/13/10 - RIFM Supports Fragrance Industry Response to Campaign for Safe Cosmetics Recent Publication

FRAGRANCE INDUSTRY FINDS NEW REPORT MISLEADING - FRAGRANCE SAFETY IS NO SECRET

5/5/10 - RIFM INFOX HELD MAY 5, 2010

Get all the details on RIFM's INFOX (Information Exchange).

4/26/10 - Free Webinar for Members

RIFM members check the Member Area of the RIFM web site for a FREE member-only event.

9/17/09 - POTENCY VALUES FROM THE LOCAL LYMPH NODE ASSAY: APPLICATION TO CLASSIFICATION, LABELING AND RISK ASSESSMENT*

Dr. Anne Marie Api, RIFM VP of Human Health Sciences, was a member of this European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) LLNA Task Force. Building on previous ECETOC work, the task force was started in mid 2007 with the remit to determine whether an EC31 potency value derived from the LLNA2 can be used to provide a cut-off criterion for the classification and labeling of both substances and preparations as a skin sensitiszer according to the Globally Harmonized System (GHS) and the Dangerous Substances and Dangerous Preparations Directives. If confirmed, develop sub-categories based on EC3 values. The task force will also evaluate the current use of LLNA data in risk assessment approaches for skin sensitization and propose a rationale for using concentration responses and corresponding no-effect concentrations by taking into account potency considerations. An article about the LLNA Task Force Report from ECETOC's most recent newsletter is reprinted by permission of the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC)



See More >